跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,459 条关于
“F18-florquinitau”
全部
2,459
临床试验
1,795
药物
569
机构
2
资讯
93
去年
Lantheus' Alzheimer's Radiodiagnostic MK-6240 Achieves Pivotal Study Success, NDA Filing Planned
上个月
FDA Approves TAUKLARIFY (Florquinitau F 18) PET Tracer for Detecting Tau Pathology in Alzheimer's Disease
去年
AngioDynamics Launches RECOVER-AV Trial for AlphaVac System in Pulmonary Embolism Treatment
11个月前
Lantheus and GE HealthCare Partner to Bring PSMA PET Imaging Agent PYLARIFY to Japan's Prostate Cancer Market
去年
Lantheus Completes $789 Million Acquisition of Life Molecular Imaging, Gains FDA-Approved Alzheimer's Diagnostic Agent
去年
Lantheus Advances Dual Alzheimer's Diagnostic Strategy with Tau and Beta-Amyloid PET Imaging Agents
去年
Kangpu Biopharmaceuticals' KPG-818 Demonstrates Favorable Safety Profile in China Bridging Study
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
Solengepras Enters Phase 3 for Parkinson's, SAGE-718 Discontinued, and Neurogene Pauses NGN-401 High-Dose Trial
10个月前
BridgeBio Reports Positive Phase 3 Results for BBP-418 in Rare Muscular Dystrophy
第 1 页,共 10 页
上一页
下一页